WanTing Liang – Trademark Portfolio

Entity Type: 01

WanTing Liang holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 2 Nice Classification classes. Currently, 2 trademarks are registered and 1 is pending. Notable registered marks include AYY and SHARECLOUD. The owner is based in Xiamen City.

2101, No. 30, Jiahe Rd, Siming Dist.

Xiamen City 361000 , CN

3 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

AYY
AYY
Registered 2025

Trademark Classifications

WanTing Liang's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

9
Computers & Electronics (1 filing)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Frequently Asked Questions

How many trademarks does WanTing Liang have?

WanTing Liang has 3 U.S. trademarks filed with the USPTO. Of these, 2 registered, 1 pending.

What trademark classes does WanTing Liang file in?

WanTing Liang files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are WanTing Liang's most well-known trademarks?

WanTing Liang's registered trademark portfolio includes well-known marks such as AYY and SHARECLOUD. These are among 2 currently registered trademarks in the portfolio.

What is WanTing Liang's trademark registration success rate?

WanTing Liang has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 1 application is pending review.